Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
International Journal of Hematology|January 26, 2019
Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemiaMasatoshi Sakurai, Taku Kikuchi, Daiki Karigane, et al.Journal of Clinical and Experimental Hematopathology : JCEH|December 16, 2014
Efficacy of molecular response at 1 or 3 months after the initiation of dasatinib treatment can predict an improved response to dasatinib in imatinib-resistant or imatinib-intolerant Japanese patients with chronic myelogenous leukemia during the chronic phaseKoiti Inokuchi, Takashi Kumagai, Eri Matsuki, et al.International Journal of Hematology|December 4, 2013
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemiaTakashi Kumagai, Eri Matsuki, Koiti Inokuchi, et al.Annals of Hematology|July 23, 2025
Autologous stem cell transplantation from 2011 to 2022 in Japanese patients aged ≥ 65 years with relapsed or refractory diffuse large B-cell lymphomaSatoshi Yamasaki, Shohei Mizuno, Kota Yoshifuji, et al.International Journal of Hematology|November 25, 2024
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit studyTsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, et al.International Journal of Hematology|March 1, 2026
Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in JapanNaoto Takahashi, Shinya Kimura, Eri Matsuki, et al.Haematologica|July 2, 2026
NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathwayEri Matsuki, Masahiro Miyata, Ryo Sato, et al.Pageof 4